Cihan Yurdaydin Selected Research

paritaprevir

1/2017

Management of hepatitis C virus infection in the Asia-Pacific region: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cihan Yurdaydin Research Topics

Disease

26	Chronic Hepatitis B 10/2023 - 09/2004
20	Fibrosis (Cirrhosis) 01/2023 - 10/2002
18	Infections 01/2022 - 10/2002
16	Hepatitis D 10/2023 - 08/2002
13	Liver Diseases (Liver Disease) 06/2021 - 08/2002
12	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 07/2005
12	Chronic Hepatitis D 01/2022 - 08/2002
10	Hepatitis B 01/2022 - 08/2002
7	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021 - 10/2002
3	Liver Neoplasms (Liver Cancer) 01/2021 - 10/2012
3	Virus Diseases (Viral Diseases) 01/2019 - 07/2003
3	Hepatitis 09/2012 - 03/2005
2	Persistent Infection 09/2023 - 09/2009
2	Chronic Hepatitis C 01/2023 - 06/2011
2	Coinfection 09/2020 - 08/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2012 - 06/2007
2	Liver Failure 02/2012 - 07/2003
2	Cholestasis 02/2006 - 04/2005
2	Fatigue 04/2005 - 09/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	COVID-19 01/2021
1	End Stage Liver Disease 12/2020
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2019
1	Massive Hepatic Necrosis 08/2015
1	Superinfection 08/2015
1	Disease Progression 01/2014
1	Hepatitis C 04/2011
1	Alcoholism (Alcohol Abuse) 09/2009
1	Viremia 06/2006
1	Type 2 Diabetes Mellitus (MODY) 11/2005
1	Obesity 11/2005

Drug/Important Bio-Agent (IBA)

16	InterferonsIBA 01/2022 - 08/2002
16	Lamivudine (Epivir)FDA Link 01/2017 - 08/2002
13	Hepatitis B e AntigensIBA 09/2023 - 07/2003
12	Tenofovir (Viread)FDA Link 10/2023 - 01/2014
12	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2002
11	Antiviral Agents (Antivirals)IBA 09/2023 - 06/2006
11	entecavir FDA Link 09/2023 - 06/2006
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 07/2003
9	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 07/2003
6	Interferon-alpha (Interferon Alfa)IBA 01/2023 - 07/2003
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2011
4	Alanine Transaminase (SGPT)IBA 01/2023 - 07/2003
4	lonafarnib (SCH 66336)IBA 01/2022 - 10/2015
4	AlbuminsIBA 06/2021 - 06/2011
3	AntigensIBA 01/2022 - 07/2003
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 09/2004
3	adefovirIBA 12/2015 - 01/2012
2	LipidsIBA 10/2023 - 11/2005
2	Ritonavir (Norvir)FDA Link 01/2022 - 01/2017
2	TransferasesIBA 01/2017 - 06/2011
2	NucleosidesIBA 01/2017 - 08/2002
2	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 04/2011
2	EnzymesIBA 12/2015 - 08/2002
2	Immunoglobulin M (IgM)IBA 01/2014 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 02/2012 - 03/2005
2	PPAR alphaIBA 12/2008 - 11/2005
2	Hepatitis B Core AntigensIBA 06/2006 - 03/2003
2	Serotonin (5 Hydroxytryptamine)IBA 02/2006 - 04/2005
1	HDL LipoproteinsIBA 10/2023
1	tenofovir alafenamideIBA 10/2023
1	CholesterolIBA 10/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Circular DNAIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 10/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	CopperIBA 01/2019
1	RacivirIBA 01/2017
1	Cholinesterases (Cholinesterase)IBA 01/2017
1	SofosbuvirIBA 01/2017
1	Emtricitabine (Emtriva)FDA Link 01/2017
1	dasabuvirIBA 01/2017
1	NucleotidesIBA 01/2017
1	nasIBA 01/2017
1	ombitasvirIBA 01/2017
1	lipoarabinomannan (LAM)IBA 01/2017
1	daclatasvirIBA 01/2017
1	paritaprevirIBA 01/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2017
1	clemizoleIBA 02/2013
1	Interferon Type IIBA 01/2012
1	Hyaluronic Acid (Hyaluronan)IBA 06/2011
1	CollagenIBA 06/2011
1	Laminin (Merosin)IBA 06/2011
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2011
1	Collagen Type III (Type III Collagen)IBA 06/2011
1	Telbivudine FDA Link 05/2011
1	AflatoxinsIBA 09/2009
1	Surface Antigens (Surface Antigen)IBA 04/2009
1	Taurine FDA Link 06/2007
1	Hydroxyproline (4 Hydroxyproline)IBA 06/2007
1	adefovir dipivoxil (Hepsera)FDA Link 01/2007
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2006

Therapy/Procedure

25	Therapeutics 01/2021 - 08/2002
8	Liver Transplantation 01/2021 - 01/2012
1	Duration of Therapy 01/2018
1	Aftercare (After-Treatment) 12/2015
1	Lasers (Laser) 02/2012